OverviewChartNewsTraderScreen

Autolus Therapeutics Plc/  US05280R1005  /

IEX
2024-05-01  7:11:12 PM Chg. +0.10 Volume Bid- Ask- High Low
3.79USD +2.57% 58,798
Turnover: 218,715.62		 -Bid Size: - -Ask Size: - 3.84 3.63
GlobeNewswire 04-24 Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of ob...
GlobeNewswire 04-23 Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May ...
GlobeNewswire 04-15 CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
GlobeNewswire 04-02 Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the Europe...
GlobeNewswire 04-01 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 03-28 CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientif...
GlobeNewswire 03-25 AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Co...
GlobeNewswire 03-20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 03-14 Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire 03-12 Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certificati...
GlobeNewswire 03-11 Autolus Therapeutics announces publication in Blood Cancer Journal
GlobeNewswire 02-29 Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 20...
GlobeNewswire 02-22 Autolus Therapeutics announces publication in Nature Communications 
Newsfile Corp 02-15 Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
GlobeNewswire 02-08 Autolus Announces Pricing of Underwritten Offering
GlobeNewswire 02-08 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 02-08 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 01-23 Autolus Therapeutics announces publication in ACS Chemical Biology
GlobeNewswire 01-22 Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleuc...
GlobeNewswire 2023-12-22 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 2023-12-10 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annu...
GlobeNewswire 2023-11-27 Autolus Therapeutics Submits Biologics License Application to U.S. Food and Drug Administration for ...
GlobeNewswire 2023-11-15 Autolus Therapeutics to Host Analyst / Investor event at the American Society of Hematology (ASH) An...
GlobeNewswire 2023-11-06 Autolus Therapeutics announces participation in upcoming conferences
GlobeNewswire 2023-11-02 Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) An...